Murielle Maire

Title: Murielle Maire: Innovator in Thrombotic Disease Solutions

Introduction

Murielle Maire is a prominent inventor based in Villetaneuse, France. She is known for her contributions to medical research, particularly in the field of thrombotic diseases. With a significant innovation under her name, she has made strides in developing therapeutic solutions that target blood clotting disorders.

Latest Patents

Maire holds a patent for "Aminofucoidan as a vector for fibrinolysis in thrombotic diseases." This invention relates to a vector designed to target thrombus, incorporating a t-PA binding property. The unique structure consists of a thrombus targeting fucoidan moiety that is covalently linked to one or more t-PA binding amino groups by the reducing end of the fucoidan moiety. This approach aims to enhance treatment efficacy for patients suffering from thrombotic conditions.

Career Highlights

Throughout her career, Murielle has contributed to prestigious institutions like the Institut National de la Santé et de la Recherche Médicale and Université Paris XIII Paris-Nord. Her roles at these establishments have allowed her to collaborate on innovative medical research initiatives, paving the way for advancements in patient care.

Collaborations

Maire has worked alongside notable colleagues, such as Stephane Loyau and Martine Jandrot-Perrus. Their combined efforts and expertise have strengthened the research efforts focused on thrombotic diseases, fostering a collaborative environment for scientific advancement.

Conclusion

Murielle Maire exemplifies the spirit of innovation in the medical field. With her patented invention, she has laid the groundwork for new therapeutic strategies to combat thrombotic diseases. Her career reflects a commitment to improving health outcomes, making her an influential figure among contemporary inventors in medical research.